drug
(sodium nitrite + sodium thiosulfate)
Marketedupdated 5mo agoby Hope Biosciences LLC
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Patent cliff
source: FDA Orange Bookfirst barrier falls
Feb 10, 2030
~3.4 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (8)
- Dec 24, 2031compositionUS 8568793
- Mar 29, 2031compositionUS 84969734.5y
- Jul 7, 2030formulationUS 104796863.8y
- Jul 7, 2030compositionUS 93457243.8y
- Jul 7, 2030compositionUS 95859123.8y
- Feb 10, 2030compositionUS 117533013.4y
- Feb 10, 2030formulationUS 123048133.4y
- Feb 10, 2030formulationUS 96875063.4y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 2h ago
Found something off?
comments(0)
5-min edit window · permanent after that